Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

New robotic bronchoscopy may be safer and more effective way to perform lung nodule biopsies

Lung nodule biopsies performed with new robotic bronchoscopy technology may be safer and more effective than those done by traditional methods, a study by researchers at UT Southwestern suggests.

20 Dec 2022

Phenotypic plasticity may allow cancer cells to evade standard therapy

Glioblastomas (GBMs) are incurable brain tumors with a prognosis of about one-and-a half years on average. They are highly resistant to treatment and have defied all attempts at precision therapy.

20 Dec 2022

The infection potential of influenza A viruses H3 subtype of avian, equine, and swine origin in humans

Researchers determined the zoonotic transmission potential of influenza A viruses (IAVs) H3 subtype of avian, equine, and swine origin.

20 Dec 2022

Non-invasive artificial intelligence approach for IVF embryo selection

An artificial intelligence algorithm can determine non-invasively, with about 70 percent accuracy, if an in vitro fertilized embryo has a normal or abnormal number of chromosomes, according to a new study from researchers at Weill Cornell Medicine.

20 Dec 2022

Hand-held biosensor enables rapid and accurate detection of oral cancer

Oral cancer is the 13th most common type of cancer globally, and oral squamous cell carcinomas (OSCCs) account for more than 90% of oral cancers.

13 Dec 2022

Owlstone Medical Presents Breath Biopsy® VOC Atlas

Owlstone Medical has embarked on an exciting project to better understand the diversity of molecules in a given breath sample

From Owlstone Medical Ltd 7 Dec 2022

Innovative precision oncology enabled by micro-organospheres derived from patients

The development of an automatic microfluidics droplet platform to rapidly generate patient-derived models of cancer.

6 Dec 2022

AI could make doctors’ work simpler, faster, and more precise

One in nine women in the developed world will be diagnosed with breast cancer at some point in her life. The prevalence of breast cancer is increasing, an effect caused in part by the modern lifestyle and increased lifespans.

2 Dec 2022

Researchers develop 3D organoid model to advance understanding of gastroesophageal junction cancer

Researchers at Johns Hopkins Medicine say they have created a laboratory-grown three-dimensional "organoid" model that is derived from human tissue and designed to advance understanding about how early stages of cancer develop at the gastroesophageal junction (GEJ) — the point where the digestive system's food tube meets the stomach.

1 Dec 2022

Blood tests may be able to guide treatment discussions for patients with metastatic cancer

As cancers grow and potentially spread to new parts of the body, they often shed cells and DNA into the blood stream. DNA can be analyzed for both the amount of DNA present and whether any potential mutations exist that may aid providers in deciding on treatments.

29 Nov 2022

One in five women likely to forgo additional testing after abnormal mammogram

One in five women is likely to forgo additional testing after an abnormal finding on a screening mammogram if there is a deductible, according to a new study presented today at the annual meeting of the Radiological Society of North America.

29 Nov 2022

Realistic 3D-Printed Thoracic Models for Surgical Training

At MEDICA 2022, NewsMedical spoke with Heike and Thorsen Walles, founders of MD2B LifeScience, which provides realistic thorax models for surgical and implant training. These 3D-printed models could revolutionize how training is approached, with replaceable ribs that replicate the behavior of actual human bones.

From MD2B Life Science GmbH 28 Nov 2022

Low-dose CT screening improves survival rate of lung cancer patients

Diagnosing early-stage lung cancer with low-dose computed tomography (CT) screening drastically improves the survival rate of cancer patients over a 20-year period, according to a large-scale international study being presented by Mount Sinai researchers at the annual meeting of the Radiological Society of North America.

22 Nov 2022

Evaluating cell-free DNA-based blood tests for early detection of multiple cancers

Researchers assessed several approaches for a circulating cell-free deoxyribonucleic acid (cfDNA)-based multi-cancer early detection (MCED) test. Defining the clinical limit of detection (LOD) based on circulating tumor allele fraction (cTAF) enables the comparison of different approaches.

21 Nov 2022

Machine learning algorithm predicts a tumor’s response to immune checkpoint blockade

Predicting which patients will respond well to treatment is a quandary that has plagued the field of cancer immunotherapy for more than four decades.

16 Nov 2022

New $3.5 million NCI grant to help improve care for cervical cancer patients in Botswana

For more than two decades, experts at Penn Medicine have worked hand in hand with local partners to improve health care and outcomes in the sub-Saharan African nation of Botswana.

11 Nov 2022

People with Alzheimer's disease can be identified before any symptoms appear

A large study led by Lund University in Sweden has shown that people with Alzheimer's disease can now be identified before they experience any symptoms.

11 Nov 2022

Study finds low absolute risk of glomerular disease relapse associated with COVID-19 vaccination

Several reports have described a relapse of certain autoimmune kidney diseases in patients after they've received COVID-19 vaccines, but it's unclear if this association is real or a coincidence.

4 Nov 2022

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

More companies around the world continue turning to Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, for their next generation sequencing (NGS) needs with the Biomek NGeniuS System.

From Beckman Coulter Life Sciences 4 Nov 2022

Polygenic hazard score could be effective for predicting genetic risk of lethal prostate cancer

Tapping into the Million Veteran Program, an ongoing national research effort to learn how genes, lifestyle and military exposures affect the health of participants, researchers at University of California San Diego School of Medicine and the VA San Diego Healthcare System, with colleagues elsewhere, report that a polygenic hazard score based on 290 genetic variants could be an effective tool for predicting genetic risk of lethal prostate cancer.

31 Oct 2022

Biopsy News and Research

Further Reading

New robotic bronchoscopy may be safer and more effective way to perform lung nodule biopsies

Phenotypic plasticity may allow cancer cells to evade standard therapy

The infection potential of influenza A viruses H3 subtype of avian, equine, and swine origin in humans

Non-invasive artificial intelligence approach for IVF embryo selection

Hand-held biosensor enables rapid and accurate detection of oral cancer

Owlstone Medical Presents Breath Biopsy® VOC Atlas

Innovative precision oncology enabled by micro-organospheres derived from patients

AI could make doctors’ work simpler, faster, and more precise

Researchers develop 3D organoid model to advance understanding of gastroesophageal junction cancer

Blood tests may be able to guide treatment discussions for patients with metastatic cancer

One in five women likely to forgo additional testing after abnormal mammogram

Realistic 3D-Printed Thoracic Models for Surgical Training

Low-dose CT screening improves survival rate of lung cancer patients

Evaluating cell-free DNA-based blood tests for early detection of multiple cancers

Machine learning algorithm predicts a tumor’s response to immune checkpoint blockade

New $3.5 million NCI grant to help improve care for cervical cancer patients in Botswana

People with Alzheimer's disease can be identified before any symptoms appear

Study finds low absolute risk of glomerular disease relapse associated with COVID-19 vaccination

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

Polygenic hazard score could be effective for predicting genetic risk of lethal prostate cancer

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News